ROCHE DIAGNOSTICS (SUISSE ROCHE group) and MILLENIUM PHARMACEUTICALS INC with its subsidiary MILLENIUM PREDICTIVE MEDECINE INC have concluded a research agreement to develop diagnostic products in the field of polyarthrite rheumatoid.